Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients.

For reimbursement options and information on help paying for Amgen medications in the U.S., please visit amgensupportplus.com for more information.

Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.

Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.

Amgen harnesses the best of biotechnology to fight the world's toughest diseases, and make people's lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative human therapeutics.

Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

2025年2月4日 · Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

Today, Amgen shared its 2024 fourth quarter and full year earnings report. Amgen’s more than 27,000 employees are united by our mission to serve patients. We harness the best of biology and technology to fight the world’s toughest diseases, and …

2025年1月24日 · Amgen opened its newest cutting-edge drug substance facility in Holly Springs, North Carolina, with a ribbon cutting ceremony on January 24. The event took place less than two months after the biotech leader announced plans for an additional $1 billion expansion at the Amgen North Carolina site to meet growing demand for Amgen’s innovative ...